MCA
NVO

MSH Capital Advisors’s Novo Nordisk NVO Stock Holding History

MSH Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
25,293
+1,871
+8% +$80.4K 0.21% 110
2026
Q1 		$861K Buy
23,422
+7,272
+45% +$345K 0.18% 124
2025
Q4 		$822K Buy
16,150
+727
+5% +$37.2K 0.18% 130
2025
Q3 		$856K Buy
+15,423
New +$903K 0.23% 115
2023
Q4 		– Sell
-2,392
Closed -$218K – 224
2023
Q3 		$218K Sell
2,392
-354
-13% -$31.2K 0.09% 195
2023
Q2 		$222K Buy
2,746
+54
+2% +$4.41K 0.08% 198
2023
Q1 		$214K Buy
+2,692
New +$191K 0.09% 184

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MSH Capital Advisors's NVO Position: Q2 2026 in Review

MSH Capital Advisors increased its Novo Nordisk (NVO) stake by 8% in Q2 2026, buying an estimated $80.4K and bringing the position to 25,293 shares worth $1.21M. The position accounts for 0.21% of the portfolio, ranked #110.

MSH Capital Advisors first reported a position in NVO in Q1 2023 and has held it in 7 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MSH Capital Advisors held 25,293 shares of Novo Nordisk worth $1.21M as of Q2 2026.
  • MSH Capital Advisors bought 1,871 Novo Nordisk shares in Q2 2026, an estimated $80.4K.
  • Novo Nordisk made up 0.21% of MSH Capital Advisors's portfolio in Q2 2026, its #110 holding.
  • MSH Capital Advisors first reported a position in Novo Nordisk in Q1 2023 and has held it in 7 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MSH Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.